BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16981420)

  • 1. [Granulomatous hepatitis successfully treated with ursodeoxycholic acid].
    Németh E; Bugovics E; Lengyel G; Pécsi G; Schaff Z; Fehér J
    Orv Hetil; 2006 Aug; 147(31):1465-70. PubMed ID: 16981420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary sclerosing cholangitis with itching treated during pregnancy with ursodeoxycholic acid].
    Christensen KL; Andersen BN; Vilstrup H
    Ugeskr Laeger; 1997 Nov; 159(48):7151-3. PubMed ID: 9417723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary sclerosing cholangitis.
    Zein CO; Lindor KD
    Semin Gastrointest Dis; 2001 Apr; 12(2):103-12. PubMed ID: 11352117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective single-center review of primary sclerosing cholangitis in children.
    Miloh T; Arnon R; Shneider B; Suchy F; Kerkar N
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):239-45. PubMed ID: 19121649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
    Stiehl A
    Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic option with N-acetylcysteine for primary sclerosing cholangitis: two case reports.
    Ozdil B; Cosar A; Akkiz H; Sandikci M; Kece C
    Am J Ther; 2011 May; 18(3):e71-4. PubMed ID: 20019586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary sclerosing cholangitis.
    Geonzon-Gonzales MR
    Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
    Wolf JM; Rybicki LA; Lashner BA
    Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune hepatitis 2 years after the diagnosis of primary sclerosing cholangitis: an unusual overlap syndrome in a 17-year-old adolescent.
    Mueller T; Bianchi L; Menges M
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):232-6. PubMed ID: 18301306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for NASH: the value of histology.
    Elitsur Y; Lawrence Z; Wang R; Durst PR
    Am J Gastroenterol; 2005 Jan; 100(1):250-1. PubMed ID: 15654810
    [No Abstract]   [Full Text] [Related]  

  • 12. The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid.
    Rudolph G; Kloeters-Plachky P; Rost D; Stiehl A
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):487-91. PubMed ID: 17489059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary sclerosing cholangitis: summary of a workshop.
    LaRusso NF; Shneider BL; Black D; Gores GJ; James SP; Doo E; Hoofnagle JH
    Hepatology; 2006 Sep; 44(3):746-64. PubMed ID: 16941705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoimmune cholangitis or seronegative biliary cirrhosis: report of one case].
    Ndongo S; Mbengue M; Dia D; Seck SM; Ka MM; Moreira Diop T
    Dakar Med; 2008; 53(2):127-30. PubMed ID: 19634547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The medical management of primary sclerosing cholangitis.
    Cullen SN; Chapman RW
    Semin Liver Dis; 2006 Feb; 26(1):52-61. PubMed ID: 16496233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ursodeoxycholic acid treatment in intrahepatic cholestasis of pregnancy. A case report].
    Lengyel G; Fehér R; Gardó S; Fehér J
    Orv Hetil; 2002 Dec; 143(52):2885-8. PubMed ID: 12638316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for therapy of autoimmune liver disease.
    Ishibashi H; Komori A; Shimoda S; Gershwin ME
    Semin Liver Dis; 2007 May; 27(2):214-26. PubMed ID: 17520519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-liver transplant cholestatic disorder with biliary strictures: de novo versus recurrent primary sclerosing cholangitis.
    McPartland KJ; Lewis WD; Gordon FD; Pomfret EA; Pomposelli JJ; Jenkins R; Khettry U
    Pathol Int; 2009 May; 59(5):312-6. PubMed ID: 19432673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholestatic liver disease in long-term infantile nephropathic cystinosis.
    Cornelis T; Claes K; Gillard P; Nijs E; Roskams T; Lombaerts R; Nevens F; Cassiman D
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e428-31. PubMed ID: 18466290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
    Beuers U
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):318-28. PubMed ID: 16741551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.